Focal distribution of hepatitis C virus RNA in infected livers.
BACKGROUND
Hepatitis C virus (HCV) is a plus-strand RNA virus that replicates by amplification of genomic RNA from minus strands leading to accumulation of almost one thousand copies per cell under in vitro cell culture conditions. In contrast, HCV RNA copy numbers in livers of infected patients appear to be much lower, estimated at a few copies per cell.


RESULTS
To gain insights into mechanisms that control HCV replication in vivo, we analyzed HCV RNA levels as well as expression of interferon beta (IFNbeta) and several interferon stimulated genes (ISGs) from whole liver sections and micro-dissected subpopulations of hepatocytes in biopsy samples from 21 HCV-infected patients. The results showed that intrahepatic HCV RNA levels range form less than one copy per hepatocyte to a maximum of about eight. A correlation existed between viral RNA levels and IFNbeta expression, but not between viral RNA and ISG levels. Also, IFNbeta expression did not correlate with ISGs levels. Replication of HCV RNA occurred in focal areas in the liver in the presence of a general induction of ISGs.


CONCLUSIONS
The low average levels of HCV RNA in biopsy samples can be explained by focal distribution of infected hepatocytes. HCV replication directly induces IFNbeta, which then activates ISGs. The apparent lack of a correlation between levels of IFNbeta and ISG expression indicates that control of the innate immune response during HCV infections depends on multiple factors.
Stiffler
J David
JD
Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
Nguyen
Minhhuyen
M
Sohn
Ji A
JA
Liu
Chen
C
Kaplan
David
D
Seeger
Christoph
C
D015153:Blotting, Western; D015331:Cohort Studies; D018628:Gene Dosage; D016174:Hepacivirus / Q000235:genetics*; D006526:Hepatitis C / Q000188:drug therapy / Q000821:virology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism* / Q000821:virology; D012367:RNA, Viral / Q000378:metabolism*
D012367:RNA, Viral; D007372:Interferons
Nature. 2005 Aug 18;436(7053):967-72
16107837
J Virol. 2005 Nov;79(21):13594-605
16227280
J Virol. 2001 Aug;75(15):7059-66
11435586
Cell Death Differ. 2008 Nov;15(11):1804-11
18756281
Hepatology. 2005 Sep;42(3):702-10
16108059
Hepatology. 2002 Jul;36(1):202-10
12085366
Hepatology. 1998 May;27(5):1428-34
9581702
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15669-74
12441396
Hepatology. 2002 Mar;35(3):680-7
11870384
J Virol. 2001 Sep;75(18):8516-23
11507197
Liver Transpl. 2006 Feb;12(2):207-16
16447184
J Virol. 2003 Sep;77(17):9204-10
12915536
Lancet Infect Dis. 2005 Sep;5(9):558-67
16122679
Science. 2000 Dec 8;290(5498):1972-4
11110665
Annu Rev Biochem. 1998;67:227-64
9759489
J Virol. 1995 Dec;69(12):8079-83
7494326
Gastroenterology. 2009 Apr;136(4):1391-401
19185579
Virology. 1992 Oct;190(2):856-60
1381540
J Virol. 2004 Dec;78(24):13779-92
15564486
Immunol Rev. 2007 Dec;220:214-24
17979849
J Hepatol. 2004 Apr;40(4):682-8
15030986
Science. 1998 Oct 2;282(5386):103-7
9756471
Hepatology. 2000 Jan;31(1):241-6
10613753
Hepatology. 2006 Mar;43(3):615-7
16496328
Hepatology. 2002 Mar;35(3):694-703
11870386
Nature. 2005 Oct 20;437(7062):1167-72
16177806
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):6001-6
16585524
PLoS Pathog. 2009 Feb;5(2):e1000291
19242562
J Virol. 2006 Mar;80(5):2280-90
16474135